Lv11
60 积分 2021-12-07 加入
Targeting Cancer Cell Dormancy
2小时前
已完结
Dormant, quiescent, tolerant and persister cells: Four synonyms for the same target in cancer
1个月前
已完结
Targeting therapy-persistent residual disease
2个月前
已完结
Mechanism of Drug Tolerant Persister Cancer Cells: The Landscape and Clinical Implication for Therapy
2个月前
已完结
Cancer drug-tolerant persister cells: from biological questions to clinical opportunities
2个月前
已完结
Drug-tolerant persister cells in cancer: the cutting edges and future directions
2个月前
已完结
First-line concomitant EGFR-TKI + chemotherapy versus EGFR-TKI alone for advanced EGFR -mutated NSCLC: a meta-analysis of randomized phase III trials
4个月前
已完结
Stepwise prolongation of overall survival from first to third generation EGFR-TKIs for EGFR mutation-positive non-small-cell lung cancer: the Tokushukai REAl-world Data project (TREAD 01)
6个月前
已完结
Osimertinib with Chemotherapy in EGFR -Mutated NSCLC
6个月前
已完结
Non-small cell lung cancer: an update on emerging EGFR-targeted therapies
6个月前
已完结
皖公网安备34019202002308
